Aminopurvalanol A (Synonyms: NG 97) |
Catalog No.GC11410
One-Click Copy Product Info
|
Aminopurvalanol A는 Cyclins/Cdk 복합체의 강력하고 선택적인 세포 투과성 억제제입니다. Aminopurvalanol A는 암세포 분화를 억제하는 G2/M-phase transition을 우선적으로 표적으로 합니다. Aminopurvalanol A는 생리학적 능력 의존적 액틴 중합의 억제를 통해 정자 수정 능력의 억제를 유발합니다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 220792-57-4
Sample solution is provided at 25 µL, 10mM.
_1-3.$$$39978408@51.jpg');)
_1-9.$$$38538795@65.jpg');)
_1-9.$$$39112701@51.jpg');)
_1-7.$$$37316672@70.jpg');)
_366-372.$$$36198801@70.jpg');)
.$$$38565142@65.jpg');)
_1867-1883.$$$33248023@67.jpg');)
_eads6055.$$$39977546@45.jpg');)
_eadm9805.$$$40080571@45.jpg');)
_eadj3020.$$$39666821@45.jpg');)
_1-20.$$$39757301@28.jpg');)
_1-24.$$$38898113@28.jpg');)
_273-287.$$$36806353@46.jpg');)
_1-16.$$$37156877@44.jpg');)
_1-19.$$$37460805@44.jpg');)
_1291-1307.$$$34518654@46.jpg');)
| Cas No. | 220792-57-4 | SDF | |
| Synonyms | NG 97 | ||
| Chemical Name | (R)-2-((6-((3-amino-5-chlorophenyl)amino)-9-isopropyl-9H-purin-2-yl)amino)-3-methylbutan-1-ol | ||
| Canonical SMILES | ClC1=CC(N)=CC(NC(N=C(N=C23)N[C@@H](CO)C(C)C)=C3N=CN2C(C)C)=C1 | ||
| Formula | C19H26ClN7O | M.Wt | 403.91 |
| Solubility | DMF: 50 mg/ml,DMF:PBS (pH 7.2) (1:5): 0.2 mg/ml,DMSO: 30 mg/ml,Ethanol: 10 mg/ml | Storage | Store at -20°C |
| General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
| Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. | ||
| Prepare stock solution | |||
|
1 mg | 5 mg | 10 mg |
| 1 mM | 2.4758 mL | 12.379 mL | 24.758 mL |
| 5 mM | 495.2 μL | 2.4758 mL | 4.9516 mL |
| 10 mM | 247.6 μL | 1.2379 mL | 2.4758 mL |
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
g
μL
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL saline, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Quality Control & SDS
- View current batch:
- Purity: >98.00% Appearance: A solid
- COA (Certificate of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Average Rating: 5 (Based on Reviews and 26 reference(s) in Google Scholar.)